PKS™ Reporter is part of the Pharsight® Knowledgebase Suite™, specifically designed to meet the regulatory compliance and validation needs of clinical pharmacology and drug metabolism groups. Key features include:
In combination with your SOPs and the Pharsight Knowledgebase Server, PKS Reporter can help you achieve full compliance with FDA regulation 21 CFR Part 11 (Electronic Records; Electronic Signatures; Final Rule).
PKS Reporter supports document authoring, review and approval using electronic signatures, reason for change capture, and comprehensive audit trails to store and manage Word documents containing PK/PD data and analysis results from WinNonlin Enterprise and other analysis tools. Analysis and modeling results are linked back to the underlying study data and changes to the data, such as rerunning analysis or loading additional data, cause the linked report elements to be marked for possible updates and review.
PKS Reporter can provide full versioning and audit trail control over finished reports, by using the capabilities of PKS to manage the report file along with all supporting data and analyses needed for a regulatory submission.
PKS Reporter and the Pharsight Knowledgebase Server are intended to be validated as a "closed system" compliant with Electronic Records; Electronic Signatures; Final Rule (21 CFR Part 11) and Guidance for Industry – Computerized Systems Used in Clinical Trials, deployed on a pharmaceutical R&D organization’s intranet.
"SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ®indicates USA registration."